AACE Endocrinology and Diabetes · Feb 17, 2026

A Heavy Price for Lightness: Pulmonary Embolism Following Tirzepatide Initiation

By Aleem M, Ur Rehman H

BACKGROUND/OBJECTIVE: Pulmonary embolism (PE) is a multifactorial thromboembolic disorder, with obesity and inherited thrombophilia among its recognized risk factors. Tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, is increasingly used for weight management, but its relationship with thromboembolic events is unclear. The objective of this report is to describe a patient with PE occurring shortly after initiation of tirzepatide, highlighting a distinctive clinical scenario in a patient with underlying predisposing factors. CASE REPORT: A 35-year-old woman with a body mass index of 42 kg/m² presented with 1 day of right-sided pleuritic chest pain and dyspnea. She denied fever, hemoptysis, palpitations, calf swelling, recent travel, surgery, trauma, or oral contraceptive use. Three weeks earlier, she had started tirzepatide 2.5 mg weekly for weight management. Examination revealed tachycardia at 103 beats per minute, with otherwise unremarkable cardiopulmonary findings. Laboratory evaluation showed a D-dimer level of 607 ng/mL (reference <278 ng/mL). Computed tomography pulmonary angiography showed extensive pulmonary emboli in the right pulmonary artery and branches, with additional filling defects in the left lower lobe. Thrombophilia testing revealed heterozygosity for the prothrombin G20210A mutation. We treated her with apixaban and discontinued tirzepatide. She remained stable at the 2-month follow-up. DISCUSSION: Thromboembolic events have been rarely reported with glucagon-like peptide-1 receptor agonists, though data specifically regarding tirzepatide remain limited. CONCLUSION: This case illustrates PE occurring shortly after tirzepatide initiation. Clinicians should be aware of potential thromboembolic events as a possible complication in high-risk patients and conduct careful risk assessment and patient counseling when initiating therapy.

doi.org/10.1016/j.aed.2026.02.005Open accessPubMed 42978756Interventions

AgingResearch.News